Fluocinolone
- Generic Name
- Fluocinolone
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C21H26F2O6
- CAS Number
- 807-38-5
- Unique Ingredient Identifier
- CT1IX58L9S
- Background
Fluocinolone has been used in trials studying the treatment and prevention of Candida Infection, Oral Lichen Planus, Macular Degeneration, and Choroidal Neovascularization.
- Associated Conditions
- -
- Associated Therapies
- -
The Use of Probiotics in Patients With Symptomatic Oral Lichen Planus
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-12-06
- Last Posted Date
- 2015-12-11
- Lead Sponsor
- University of Copenhagen
- Target Recruit Count
- 25
- Registration Number
- NCT01743690
- Locations
- 🇩🇰
University of Copenhagen, Copenhagen, Denmark
Fluocinolone Implant to Treat Macular Degeneration
Phase 1
Completed
- Conditions
- First Posted Date
- 2001-01-15
- Last Posted Date
- 2008-03-04
- Lead Sponsor
- National Eye Institute (NEI)
- Target Recruit Count
- 16
- Registration Number
- NCT00008515
- Locations
- 🇺🇸
National Eye Institute (NEI), Bethesda, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath